Inactive Instrument

GX Acquisition Corp. Stock

GXGX

US36251A1079

Latest news about GX Acquisition Corp.

Celularity Closes Merger With GX Acquisition Corp	21-07-16	MT
Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction.	21-07-15	CI
GX Acquisition Corp. Approves Elections of Nine Directors	21-07-15	CI
GX Acquisition Corp.(NasdaqCM:GXGX) dropped from NASDAQ Composite Index	21-07-15	CI
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
Palantir Technologies : Working With Celularity to Advance Cellular Therapies	21-05-05	MT
GX ACQUISITION : BTIG Research Starts GX Acquisition at Buy With $16 Price Target	21-03-26	MT
Gx Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-04	CI
Transcript : Celularity Inc., GX Acquisition Corp. - M&A Call	21-01-08
GX Acquisition : Celularity, GX Acquisition Corp. to Merge, Create a Publicly Listed Allogeneic Cellular Therapy Company	21-01-08	MT
Celularity Inc. entered into non-binding letter of intent to acquire GX Acquisition Corp. for $1.7 billion in a reverse merger transaction.	21-01-07	CI
Gx Acquisition Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Gx Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-13	CI
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-15	CI
Gx Acquisition Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-13	CI

More news

Analyst Recommendations on GX Acquisition Corp.

GX ACQUISITION : BTIG Research Starts GX Acquisition at Buy With $16 Price Target

21-03-26

More recommendations

Press releases GX Acquisition Corp.

GX Acquisition : Clinical pipeline includes multiple clinical stage programs including acute myeloid leukemia (AML) and glioblastoma multiforme (GBM), with a total of five clinical programs expected by 1H 2022 (Form 8-K)	21-07-22	PU
GX Acquisition : Submission of Matters to a Vote of Security Holders (Form 8-K)	21-07-15	PU
GX ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	21-07-15	AQ
GX Acquisition : Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States (Form 8-K)	21-07-01	PU
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21-07-01	AQ

More press releases

GX Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations and it has not generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+103.83%	4.88B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+27.88%	836M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+1.80%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+26.89%	578M

Shell Companies